loading page

Clinical Manifestations and Associated Mortality Factors of COVID-19: A large population-based study in Northeast of Iran: 2020-2021
  • +4
  • MohammadTaghi Shakeri,
  • AmirAli Moodi-Ghalibaf,
  • Masood GhodsiMoghadam,
  • Parham Ahmadi,
  • Ghazaleh Ghorbannezhad,
  • Samaneh Abolbashari,
  • Maryam Salari
MohammadTaghi Shakeri
Mashhad University of Medical Sciences
Author Profile
AmirAli Moodi-Ghalibaf
Mashhad University of Medical Sciences
Author Profile
Masood GhodsiMoghadam
Mashhad University of Medical Sciences
Author Profile
Parham Ahmadi
Mashhad University of Medical Sciences
Author Profile
Ghazaleh Ghorbannezhad
Mashhad University of Medical Sciences
Author Profile
Samaneh Abolbashari
Mashhad University of Medical Sciences
Author Profile
Maryam Salari
Mashhad University of Medical Sciences

Corresponding Author:salarimr@mums.ac.ir

Author Profile

Abstract

Background: The emergence of the coronavirus disease in late 2019 (COVID-19) has become one of the greatest health problems of the 21st century. Many aspects of this viral disease are still hidden. The current study is conducted to investigate COVID-19’s clinical manifestation, mortality factors, and their association with each other in the COVID-19 pandemic in Razavi-Khorasan province, Iran. Methods & Materials: This retrospective epidemiological population-based study was conducted from January 21, 2020, to March 20, 2021. The data including demographic characteristics and clinical presentations of the patients were extracted from the Medical Care Monitoring System (MCMC), disease management portal in the deputy of health and Hospital Information System (HIS). Results: A total of 80499 patients were admitted to all hospitals of Khorasan-Razavi University of Medical Sciences with laboratory/clinical COVID-19 confirmed disease, between January 2020 and March 2021. The male-to-female ratio was 1.10:1 and the mean age of our COVID-19 individuals was 55.67 ± 23.27. The most frequently reported presenting symptoms at admission were respiratory distress (58.2%), fever (36.7%), and cough (34.9%), and alternation in smell/taste (0.9%) was the less frequent. Being male, aging older than 60 years and having comorbidities were significantly associated with higher mortality rates. Conclusion: Due to the genetic mutations in the virus and the emergence of the new variants of the virus, clinical presentations, and mortality rates of the COVID-19 have been shifted through three reviewed waves. Further studies are needed to determine the impact of the new variants of the virus on individuals.